Neil Thapar
Chief Executive Officer at Barricade Therapeutics.
Earliest Form D on file: Jun 2026
Filed Jun 10, 2026
Barricade Therapeutics
Oral EBP inhibitor for APC-mutant colorectal cancer
Biotech, Fort Worth TX
Signed as Chief Executive Officer
Chief Executive Officer at Barricade Therapeutics.
Earliest Form D on file: Jun 2026
Oral EBP inhibitor for APC-mutant colorectal cancer
Biotech, Fort Worth TX
Signed as Chief Executive Officer